For the 40-target panel, the trial found an overall average weighted sensitivity and specificity of 90 and 99 percent, respectively.
In PLOS this week: genetic networks involved in antibiotic sensitivity, syphilis pathogen proteome, and more.
The test is an improved version of one that was approved three years ago, and runs on the firm's illumigene molecular diagnostics platform.
The firm has also begun setting up US operations as it prepares to submit for FDA approval of its MDx system and lower respiratory tract infection diagnostic.
Cepheid will create Xpert cartridge tests to detect S. aureus and P. aeuginosa, to be used in clinical trials for biologics intended to prevent pneumonia.
A University of Alabama, Birmingham team used the Illumina MiSeq platform to perform next-generation sequencing on 15 strains of M. pneumoniae.
Meanwhile, the company is moving ahead with a clinical trial to support the assay's approval in the US.
Freeze-drying and rehydrating pooled samples may overcome problems casued by dilution of pathogen nucleic acids.
Molecular diagnostics firm Curetis this week announced the availability of new data on the clinical performance of its Unyvero P50 pneumonia cartridge in multi-pathogen infections.
Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.
Bill Gates tells the Telegraph that bioterrorism is a serious risk.
The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.
CBS News reports that the White House Science Fair is to continue under President Donald Trump.